13-38687525-G-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_207361.6(FREM2):c.181G>C(p.Ala61Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000838 in 1,598,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_207361.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FREM2 | NM_207361.6 | c.181G>C | p.Ala61Pro | missense_variant | Exon 1 of 24 | ENST00000280481.9 | NP_997244.4 | |
FREM2 | XM_017020554.2 | c.181G>C | p.Ala61Pro | missense_variant | Exon 1 of 3 | XP_016876043.1 | ||
FREM2 | XR_941571.3 | n.449G>C | non_coding_transcript_exon_variant | Exon 1 of 8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000420 AC: 64AN: 152250Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000811 AC: 18AN: 222044Hom.: 0 AF XY: 0.0000579 AC XY: 7AN XY: 120818
GnomAD4 exome AF: 0.0000477 AC: 69AN: 1446344Hom.: 0 Cov.: 30 AF XY: 0.0000348 AC XY: 25AN XY: 717728
GnomAD4 genome AF: 0.000427 AC: 65AN: 152368Hom.: 0 Cov.: 34 AF XY: 0.000322 AC XY: 24AN XY: 74500
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
- -
Isolated cryptophthalmia;C4540036:Fraser syndrome 2 Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.181G>C (p.A61P) alteration is located in exon 1 (coding exon 1) of the FREM2 gene. This alteration results from a G to C substitution at nucleotide position 181, causing the alanine (A) at amino acid position 61 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at